IS5931A - Notkun smáveiruhjúphluta til að hamla frumufjölgun og frumuflutningi - Google Patents

Notkun smáveiruhjúphluta til að hamla frumufjölgun og frumuflutningi

Info

Publication number
IS5931A
IS5931A IS5931A IS5931A IS5931A IS 5931 A IS5931 A IS 5931A IS 5931 A IS5931 A IS 5931A IS 5931 A IS5931 A IS 5931A IS 5931 A IS5931 A IS 5931A
Authority
IS
Iceland
Prior art keywords
small virus
cell proliferation
coatings
cell migration
inhibit
Prior art date
Application number
IS5931A
Other languages
English (en)
Inventor
Broliden Kristina
Westgren Magnus
Original Assignee
Broliden Kristina
Westgren Magnus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Broliden Kristina, Westgren Magnus filed Critical Broliden Kristina
Publication of IS5931A publication Critical patent/IS5931A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IS5931A 1998-11-24 2001-05-02 Notkun smáveiruhjúphluta til að hamla frumufjölgun og frumuflutningi IS5931A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9804022A SE520177C2 (sv) 1998-11-24 1998-11-24 Användning av tomma, icke-infektiösa, rekombinanta parvoviruskapsidpartiklar, eller P-antigenblockerande delar därav, för framställning av läkemedel för ihibering av hematopoietiska stamceller
PCT/IB1999/002112 WO2000030668A2 (en) 1998-11-24 1999-11-23 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration

Publications (1)

Publication Number Publication Date
IS5931A true IS5931A (is) 2001-05-02

Family

ID=20413393

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5931A IS5931A (is) 1998-11-24 2001-05-02 Notkun smáveiruhjúphluta til að hamla frumufjölgun og frumuflutningi

Country Status (14)

Country Link
EP (1) EP1131085A2 (is)
JP (1) JP2003516927A (is)
KR (1) KR20010080518A (is)
CN (1) CN1328469A (is)
AU (1) AU2566600A (is)
CA (1) CA2352043A1 (is)
CZ (1) CZ20011369A3 (is)
HU (1) HUP0104298A2 (is)
IS (1) IS5931A (is)
MX (1) MXPA01004949A (is)
NO (1) NO20012534L (is)
PL (1) PL348640A1 (is)
SE (1) SE520177C2 (is)
WO (1) WO2000030668A2 (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1275658B1 (en) * 2001-07-10 2006-11-15 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Compositions comprising a parvovirus VP1-variant and a parvovirus NS1 protein for induction of cytolysis
EP2149583B1 (en) * 2004-09-24 2015-10-28 Novartis AG Modified VP1-capsid protein of parvovirus B19
CN101475942B (zh) * 2008-11-28 2012-05-23 中国人民解放军第四军医大学 一种b19病毒vp1独特区基因
WO2012159006A2 (en) * 2011-05-18 2012-11-22 University Of Florida Research Foundation, Inc. Polypeptides and vectors for targeting her2/neu expressing cells and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2755817B2 (ja) * 1988-11-14 1998-05-25 アメリカ合衆国 パルボウイルスキャプシド
NL8902301A (nl) * 1989-09-14 1991-04-02 Rijksuniversiteit Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.

Also Published As

Publication number Publication date
CN1328469A (zh) 2001-12-26
SE9804022L (sv) 2000-05-25
MXPA01004949A (es) 2003-03-10
HUP0104298A2 (hu) 2002-03-28
SE520177C2 (sv) 2003-06-03
CA2352043A1 (en) 2000-06-02
SE9804022D0 (sv) 1998-11-24
JP2003516927A (ja) 2003-05-20
KR20010080518A (ko) 2001-08-22
WO2000030668A2 (en) 2000-06-02
WO2000030668A9 (en) 2001-04-05
WO2000030668A3 (en) 2000-11-09
EP1131085A2 (en) 2001-09-12
NO20012534L (no) 2001-06-29
AU2566600A (en) 2000-06-13
CZ20011369A3 (cs) 2001-10-17
PL348640A1 (en) 2002-06-03
NO20012534D0 (no) 2001-05-23
WO2000030668A8 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
EE200000706A (et) Bitsüklilised pürimidiinid ja bitsüklilised 3,4-dihüdropürimidiinid kui rakkude proliferatsiooni inhibiitorid
DE69930647D1 (de) Struktur-analoga von amin-basen und nucleosiden
ID19961A (id) Sel jenis tipis
DK199800913A (da) Fremgangsmåde til at påføre beskyttende og dekorativ coating på en genstand
DE69924589D1 (de) Einphasige Silikon- und Wasserzusammensetzung
DK0810415T3 (da) Keramisk panserplade og fremgangsmåde til fremstilling heraf
DK383989A (da) Middel til modvirkning af dannelse af overtraek og dets anvendelse
NO20001323L (no) Dipeptid-apoptose-inhibitorer og deres anvendelse
NO20005100L (no) Genetisk modifiserte celler og fremgangsmåter for ekspresjon av rekombinant heparanase og fremgangsmåter for rensing av samme
DK349486D0 (da) 4-substituerede 2-amino-5-hydroxypyrimidin-forbindelser og deres anvendelse til behandling af pulmonale, allergiske, inflammatoriske og cardiovasculaere sygdomme
DE69932024D1 (de) Rückwirkend kontrolliertes elektrochemisches Ablösen von Gasturbinen-Beschichtungen
DE69827942D1 (de) Leptin als inhibitor der tumorzellenproliferation
DK0915872T3 (da) Substituerede bisindolylmaleimider til inhibering af celleproliferation
DK0898566T3 (da) Substituerede benzylaminer og anvendelse deraf til behandling af depression
NO20014768D0 (no) Inhibitorer av LFA-1 binding til ICAM og anvemdelser derav
EP0800649A4 (en) Inhibition of glial cell proliferation
FI971934A7 (fi) Asyloituja bentsyyliglykosideja sileälihassolulisääntymisen inhibiittoreina
EP1039897A4 (en) COMPOUNDS BASED ON INADONE AND TETRALONE FOR INHIBITING CELL PROLIFERATION
DK1064279T3 (da) Substituerede bisindolylmaleimider til inhibering af celleproliferation
KR950703064A (ko) 세포증식의 저해물질, 그의 제조방법 및 이용방법
FI971936A7 (fi) Sileän lihaskudoksen solujen lisääntymisen estäjät
EE03871B1 (et) Tsüanoguanidiinid kui rakkude paljunemise inhibiitorid
DE69737017D1 (de) Verwendung von energie-bursts in schnurlosen netzwerken
IS5931A (is) Notkun smáveiruhjúphluta til að hamla frumufjölgun og frumuflutningi
DE60030944D1 (de) Nummerierung von videobjekten und -zellen